Alembic Pharmaceuticals Ltd. Continues Upward Trend, Receives 'Buy' Call from MarketsMOJO
Alembic Pharmaceuticals Ltd. (Alembic) has shown a 3.41% increase in the stock market on September 4th, 2024. This has been recognized by MarketsMojo, who have given the stock a 'Buy' call. The stock has consistently outperformed the sector and moving averages, making it a promising investment option in the pharmaceutical industry.
Alembic Pharmaceuticals Ltd. (Alembic) has continued its upward trend in the stock market, gaining 3.41% on September 4th, 2024. This positive performance has been recognized by MarketsMOJO, who have given the stock a 'Buy' call.
The stock has shown strong performance today, outperforming the sector by 3.4%. It reached an intraday high of Rs 1096.45, showing a 3.26% increase. This is a promising sign for investors, as Alembic's stock has been consistently performing well in the market.
In terms of moving averages, Alembic's stock is higher than the 5-day, 50-day, 100-day, and 200-day moving averages. However, it is lower than the 20-day moving average. This indicates a positive trend for the company's stock, as it is consistently performing above its long-term moving averages.
When compared to the overall market performance, Alembic's stock has outperformed the Sensex by 4.11% in the past day and has shown a strong 1-month performance of -10.80% compared to the Sensex's 1.42% increase. This further highlights the company's strong performance and potential for growth.
Alembic Pharmaceuticals Ltd. is a largecap company in the pharmaceutical industry. With its consistent positive performance and recognition from MarketsMOJO, it is a promising investment option for those looking to invest in the pharma sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
